Home / Market News / $UNH
benzinga Corporate Catalyst Impact 92/100 ● positive

UnitedHealth Group Q3 Adj. EPS $4.69 Beats $4.15 Estimate, Sales $112.694B Beat $111.403B Estimate

Oct 13, 2026, 9:55 AM UTC · Primary ticker $UNH

UnitedHealth Group reported strong Q3 earnings, significantly beating analyst estimates for adjusted EPS and slightly exceeding sales expectations. This positive performance indicates robust operational execution and could lead to upward revisions in future guidance and stock price appreciation for UNH.

UnitedHealth Group announced Q3 adjusted EPS of $4.69, significantly surpassing the $4.15 consensus estimate, representing a 60.62% year-over-year increase. Sales also beat expectations at $112.694 billion, though they were slightly down year-over-year. This strong earnings beat, particularly the substantial EPS growth, suggests effective cost management and strong demand for UNH's healthcare services and insurance products. This is a major positive catalyst for UNH, likely to drive short-term stock price appreciation and potentially lead to revised analyst ratings and long-term investor confidence. Traders should watch for follow-through buying and potential upgrades.

$UNH positive Strong Q3 earnings and sales beat
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.